These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 32210968)
1. Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients. Pirozyan MR; McGuire HM; Emran AA; Tseng HY; Tiffen JC; Lee JH; Carlino MS; Menzies AM; Long GV; Scolyer RA; Fazekas de St Groth B; Hersey P Front Immunol; 2020; 11():372. PubMed ID: 32210968 [TBL] [Abstract][Full Text] [Related]
3. Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients. Subrahmanyam PB; Dong Z; Gusenleitner D; Giobbie-Hurder A; Severgnini M; Zhou J; Manos M; Eastman LM; Maecker HT; Hodi FS J Immunother Cancer; 2018 Mar; 6(1):18. PubMed ID: 29510697 [TBL] [Abstract][Full Text] [Related]
4. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival. Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E Front Immunol; 2021; 12():778329. PubMed ID: 34975867 [TBL] [Abstract][Full Text] [Related]
6. Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma. Krebs FK; Trzeciak ER; Zimmer S; Özistanbullu D; Mitzel-Rink H; Meissner M; Grabbe S; Loquai C; Tuettenberg A Cancer Med; 2021 Mar; 10(5):1562-1575. PubMed ID: 33449393 [TBL] [Abstract][Full Text] [Related]
7. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. Benci JL; Johnson LR; Choa R; Xu Y; Qiu J; Zhou Z; Xu B; Ye D; Nathanson KL; June CH; Wherry EJ; Zhang NR; Ishwaran H; Hellmann MD; Wolchok JD; Kambayashi T; Minn AJ Cell; 2019 Aug; 178(4):933-948.e14. PubMed ID: 31398344 [TBL] [Abstract][Full Text] [Related]
8. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy. Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008 [TBL] [Abstract][Full Text] [Related]
9. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver. Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474 [TBL] [Abstract][Full Text] [Related]
11. Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients. Kulikowska de Nałęcz A; Ciszak L; Usnarska-Zubkiewicz L; Frydecka I; Pawlak E; Szmyrka M; Kosmaczewska A Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502204 [TBL] [Abstract][Full Text] [Related]
12. A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients. Li C; Phoon YP; Karlinsey K; Tian YF; Thapaliya S; Thongkum A; Qu L; Matz AJ; Cameron M; Cameron C; Menoret A; Funchain P; Song JM; Diaz-Montero CM; Tamilselvan B; Golden JB; Cartwright M; Rodriguez A; Bonin C; Vella A; Zhou B; Gastman BR J Exp Med; 2022 Jan; 219(1):. PubMed ID: 34807232 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy. Plesca I; Tunger A; Müller L; Wehner R; Lai X; Grimm MO; Rutella S; Bachmann M; Schmitz M Front Immunol; 2020; 11():364. PubMed ID: 32194568 [TBL] [Abstract][Full Text] [Related]
15. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer. Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241 [TBL] [Abstract][Full Text] [Related]
16. Checkpoint blockade accelerates a novel switch from an NKT-driven TNFα response toward a T cell driven IFN-γ response within the tumor microenvironment. Aoyama S; Nakagawa R; Nemoto S; Perez-Villarroel P; Mulé JJ; Mailloux AW J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34135102 [TBL] [Abstract][Full Text] [Related]
17. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles. Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546 [TBL] [Abstract][Full Text] [Related]
18. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells. Kim N; Kim HS Front Immunol; 2018; 9():2041. PubMed ID: 30250471 [TBL] [Abstract][Full Text] [Related]
19. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells. Porichis F; Hart MG; Massa A; Everett HL; Morou A; Richard J; Brassard N; Veillette M; Hassan M; Ly NL; Routy JP; Freeman GJ; Dubé M; Finzi A; Kaufmann DE J Immunol; 2018 Aug; 201(3):971-981. PubMed ID: 29934472 [TBL] [Abstract][Full Text] [Related]
20. Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8 Park J; Kwon M; Kim KH; Kim TS; Hong SH; Kim CG; Kang SG; Moon JH; Kim EH; Park SH; Chang JH; Shin EC Clin Cancer Res; 2019 Apr; 25(8):2549-2559. PubMed ID: 30659023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]